SPARK Microsystems | $12,364,525 | (Mar 24, 2026)
Meadow Memorials | $9,000,000 | (Mar 24, 2026)
Certified by Founder
Lodge
Oryon Cell Therapies
start up
United States
- Belmont, Massachusetts
- 24/03/2026
- Series A
- $21,000,000
Oryon Cell Therapies is a clinical-stage biotechnology company developing autologous cell therapies for neurodegenerative disorders, with an initial focus on Parkinson’s disease. Co-founded in 2020 by Ole Isacson, M.D. Ph.D., and Nikola Kojic, M.D., Ph.D., the company’s technology is designed to restore synaptic function and motor control by replacing neurons lost to the disease, with the goal of achieving functional restoration.
- Industry Biotechnology Research
- Website https://oryoncelltherapies.com/
- LinkedIn https://www.linkedin.com/company/oryon-cell-therapies/
Hamilton AI | $7,500,000 | (Mar 24, 2026)
Flourish Care | $5,700,000 | (Mar 24, 2026)
Interloom | $16,500,000 | (Mar 24, 2026)
eternal.ag | $9,271,160 | (Mar 24, 2026)
EGIDE | $9,266,200 | (Mar 24, 2026)
Cleavr | $1,158,600 | (Mar 24, 2026)
JAAQ | $17,416,100 | (Mar 24, 2026)
CisLunar Industries | $2,600,000 | (Mar 24, 2026)
Ezra AI Labs | $3,200,000 | (Mar 20, 2026)